However, this difference did not reach statistical significance in the VEOBC group, which we believe is primarily due to the limited number of patients in this group.
← all excerpts
Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study.
1
—
—